Tumour biopsy for pharmacodynamic (PD) study is increasingly common in early-phase cancer trials. As they are non-diagnostic, the ethical justification for such procedures rests on their knowledge ...
ENVEA reveals the importance and benefits of accurately reporting biogenic CO2 emissions to the Emissions Trading Scheme (ETS) in a new free white paper. As part of the ETS, a cap is being introduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback